New York, Sept. 21, 2017 --
The cost of providing quality healthcare is rising and this issue is faced by even the developed countries of the West. Hence providing efficient, quality and cost-effective healthcare is a priority for all. However, there is a lack of adequate funding for healthcare due to political, economic and other governance related compulsions and thus the healthcare system has to operate within this restraint. Also, even though healthcare funding and health insurance programs exist, there is a steep increase in the cost of providing quality healthcare. Due to these reasons, healthcare providers are opting for the adoption of cost curbing tools such as healthcare clinical analytics. Due to healthcare clinical analytics, tools like big data can be used to analyze large amounts of healthcare information generated and this can be used to draw inferences and conclusions that makes the entire healthcare system efficient and transparent. Due to these factors, the global healthcare clinical analytics market is growing at a brisk pace.
Global Market Research Report Overview on Healthcare Clinical Analytics @ https://www.persistencemarketresearch.com/market-research/healthcare-clinical-analytics-market.asp
The global healthcare clinical analytics market is slated to touch a value of about US$ 28,000 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
A sample of this report is available upon request@ https://www.persistencemarketresearch.com/samples/18607
4 Forecast Highlights on Global Healthcare Clinical Analytics Market
As per the forecast of Persistence Market Research, the integrated platform type segment is slated to touch a value of nearly US$ 19,000 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The integrated platform type segment is estimated to account for nearly two-thirds of the revenue share of the platform type segment by the year 2017 and is forecasted to gain market share by 2022 over 2017.
As per the forecast of Persistence Market Research, the clinics segment will reach a value of nearly US$ 850 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The clinics segment is forecasted to account for nearly one-tenth of the total revenue share of the end-user segment by the end of the year 2017 and is expected to gain in market share by 2022 as compared with the year 2017.
As per the forecast of Persistence Market Research, the on-premise segment is slated to reach a value of nearly US$ 11,600 Mn in 2022. The on-premise segment is expected to lose market share by the end of the year 2022. The largest share is contributed by the North America region in the on-premise segment.
Persistence Market Research forecasts the in-house solution type segment to exhibit a compound annual growth rate (CAGR) of about 15% from 2017 to 2022.
View Report Table of Contents, Figures, and Tables@ https://www.persistencemarketresearch.com/market-research/healthcare-clinical-analytics-market/toc
The report has also included the profiles of some of the leading companies in the healthcare clinical analytics market like Hewlett Packard Enterprise Company, Allscripts Healthcare Solutions, Inc., Cerner Corp., CareCloud Corporation, IBM Corporation, Medical Information Technology Inc., Optum Inc., McKesson Corp., Qsi Management Llc and Oracle Corp.
Global Healthcare Clinical Analytics Market Report is Available for US$ 4,900
Persistence Market Research Overview
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email: [email protected]


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



